{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:38Z","timestamp":1791230738424,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.neulet.2011.07.036","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T05:15:27Z","timestamp":1312348527000},"page":"10-13","source":"Crossref","is-referenced-by-count":9,"title":["A 5-HT2C receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference"],"prefix":"10.1016","volume":"505","author":[{"given":"John D.","family":"McCorvy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrie A.","family":"Harland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Maglathlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2011.07.036_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2008.10.010","article-title":"Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors","volume":"121","author":"Aloyo","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2011.07.036_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.07.036_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","article-title":"Conditioned place preference using opiate and stimulant drugs: a meta-analysis","volume":"19","author":"Bardo","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2011.07.036_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(08)00914-X","article-title":"Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression","volume":"172","author":"Berg","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neulet.2011.07.036_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0091-3057(94)90553-3","article-title":"Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats","volume":"48","author":"Bowling","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.07.036_bib0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/jm970741j","article-title":"Novel and selective 5-HT2C\/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure\u2013activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines","volume":"41","author":"Bromidge","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2011.07.036_bib0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2006.12.071","article-title":"Distribution of serotonin 5-HT2C receptors in the ventral tegmental area","volume":"146","author":"Bubar","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2011.07.036_bib0040","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/nprot.2006.279","article-title":"Drug-induced conditioned place preference and aversion in mice","volume":"1","author":"Cunningham","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neulet.2011.07.036_bib0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1177-9","article-title":"S32006 a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models","volume":"199","author":"Dekeyne","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.07.036_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(98)00014-8","article-title":"Selective blockade of serotonin2C\/2B receptors enhances dopamine release in the rat nucleus accumbens","volume":"37","author":"Di","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.07.036_bib0055","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.07.036_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","article-title":"Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors","volume":"865","author":"Di","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.07.036_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0091-3057(01)00705-5","article-title":"Role of serotonin(2C) receptors in the control of brain dopaminergic function","volume":"71","author":"Di","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.07.036_bib0070","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-006-0453-9","article-title":"The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists","volume":"187","author":"Fletcher","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.07.036_bib0075","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/S0028-3908(00)00089-7","article-title":"Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C\/2B) receptor antagonists: neurochemical and behavioural studies","volume":"39","author":"Hutson","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.07.036_bib0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1349","article-title":"Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse","volume":"12","author":"Ji","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2011.07.036_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/14728210903107751","article-title":"Emerging drugs for major depressive disorder","volume":"14","author":"Kennedy","year":"2009","journal-title":"Expert. Opin. Emerg. Drugs"},{"key":"10.1016\/j.neulet.2011.07.036_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/11534420-000000000-00000","article-title":"Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness","volume":"24","author":"Kennedy","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2011.07.036_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF02245448","article-title":"Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller\u2013Seifter model of anxiety","volume":"114","author":"Kennett","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.07.036_bib0100","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1471-4159.2009.06356.x","article-title":"In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist","volume":"111","author":"Leggio","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2011.07.036_bib0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.07.036_bib0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.036_bib0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tips.2006.07.003","article-title":"Intracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction","volume":"27","author":"Muller","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2011.07.036_bib0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14737175.4.6.927","article-title":"Adderall XR: long acting stimulant for single daily dosing","volume":"4","author":"Sallee","year":"2004","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.neulet.2011.07.036_bib0125","first-page":"829","article-title":"Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis","volume":"22","author":"Sanders-Bush","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neulet.2011.07.036_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(98)00062-6","article-title":"Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity","volume":"790","author":"Schildein","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.07.036_bib0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1568007033482698","article-title":"Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders","volume":"2","author":"Wood","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401101113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401101113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T19:21:55Z","timestamp":1543605715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030439401101113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S030439401101113X"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2011.07.036","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}